NYSE: CPTCamden Property Trust Stock
$110.08-0.64 (-0.58%)
Updated Dec 31, 2025
CPT Price
$110.08
Fair Value Price
N/A
Market Cap
$11.71B
52 Week Low
$97.17
52 Week High
$126.55
P/E
44.57x
P/B
2.58x
P/S
7.28x
PEG
N/A
Dividend Yield
3.82%
Revenue
$1.59B
Earnings
$269.12M
Gross Margin
61.8%
Operating Margin
25.69%
Profit Margin
16.9%
Debt to Equity
0.98
Operating Cash Flow
$782M
Beta
0.65
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
Jan 16, 2026
CPT Overview
Camden Property Trust is a Real Estate Investment Trust (REIT) that invests in apartments in the U.S. Its portfolio is primarily located in the Sun Belt, Houston, Dallas, Las Vegas, and Atlanta. The company was founded in 1981 and is headquartered in Houston, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CPT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Residential REIT
Industry Rating
F
CPT
Ranked#7 of 20
Ranked#7 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.88 | B | |
| $27.79 | C | |
| $66.72 | C |
Be the first to know about important CPT news, forecast changes, insider trades & much more!
CPT News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CPT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CPT is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CPT is poor value based on its earnings relative to its share price (44.57x), compared to the US market average (43.85x)
P/E vs Market Valuation
CPT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CPT due diligence checks available for Premium users.
Valuation
CPT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
44.57x
Industry
33.2x
Market
43.85x
CPT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CPT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CPT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.58x
Industry
2.2x
CPT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CPT's financial health
Profit margin
Revenue
$405.1M
Net Income
$108.9M
Profit Margin
26.9%
CPT's Earnings (EBIT) of $408.98M... subscribe to Premium to read more.
Interest Coverage Financials
CPT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.1B
Liabilities
$4.4B
Debt to equity
0.98
CPT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$250.9M
Investing
-$5.1M
Financing
-$253.1M
CPT's operating cash flow ($782.16M)... subscribe to Premium to read more.
Debt Coverage Financials
CPT vs Residential REIT Stocks
Camden Property Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.